For more than 70 years, Charles River Laboratories, Inc. has evolved into a worldwide support network,allowing us to act as a steadfast partner to our clients, from discovery to lot release testing for accelerating drug discovery and development. The Microbial Solutions division strategically built our portfolio to bring you progressive products and services that deliver accurate,relevant and reliable data to fuel confident decisions on product quality and contamination control. Our unique combination of Endosafe® endotoxin testing, Celsis® rapid microbial detection, and Accugenix® microbial identification and strain typing keeps your manufacturing operations running efficiently and smoothly, lowers your cost to manufacture, and protects your reputation.
At Charles River we continue to kindle the spark that inspired our founding: an urgency to advance human health by supporting our clients’ research every step of the way.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical/biopharmaceutical manufacturing science and regulation, so members can better serve patients.
www.pda.org/@company